or Try an Advanced Search...

    Technical Analysis for ETNB - 89bio, Inc.

    Grade Last Price % Change Price Change
    F 9.03 -3.63% -0.34
    ETNB closed down 3.63 percent on Wednesday, May 8, 2024, on 50 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical ETNB trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Gapped Down Weakness 0.00%
    Bearish Engulfing Bearish -3.63%
    Gapped Up Strength -3.63%
    Crossed Above 20 DMA Bullish -5.84%
    Spinning Top Other -5.84%
    Wide Bands Range Expansion -5.84%
    Gapped Up Strength -5.84%
    Up 3 Days in a Row Strength -5.84%
    Up 4 Days in a Row Strength -5.84%
    Older End-of-Day Signals for ETNB ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 13 hours ago
    Down 5% about 14 hours ago
    Fell Below 20 DMA about 16 hours ago
    20 DMA Support about 16 hours ago
    60 Minute Opening Range Breakdown about 16 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ETNB Chart by TradingView
    Basic chart:

    Profile

    89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Alcohol Hepatitis Steatohepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease Innovative Therapies

    Is ETNB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 89bio to Participate in the BofA Securities 2024 Health Care Conference
    May 2 89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH
    Apr 17 89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
    Apr 10 89bio signs deal for construction of a production facility in China
    Apr 3 89bio Inc CEO Rohan Palekar Sells 52,718 Shares
    Mar 27 89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis
    Mar 18 Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That
    Mar 13 13 Best Biotech Stocks To Buy Under $20
    Mar 12 89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosis
    Mar 8 89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    See more ETNB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.93
    52 Week Low 6.575
    Average Volume 1,117,142
    200-Day Moving Average 11.53
    50-Day Moving Average 10.72
    20-Day Moving Average 9.06
    10-Day Moving Average 8.84
    Average True Range 0.55
    RSI (14) 43.18
    ADX 18.8
    +DI 22.78
    -DI 26.54
    Chandelier Exit (Long, 3 ATRs) 9.32
    Chandelier Exit (Short, 3 ATRs) 9.69
    Upper Bollinger Bands 10.04
    Lower Bollinger Band 8.08
    Percent B (%b) 0.49
    BandWidth 21.64
    MACD Line -0.40
    MACD Signal Line -0.54
    MACD Histogram 0.1437
    Fundamentals Value
    Market Cap 841.65 Million
    Num Shares 93.2 Million
    EPS -1.80
    Price-to-Earnings (P/E) Ratio -5.02
    Price-to-Sales 0.00
    Price-to-Book 1.92
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.73
    Resistance 3 (R3) 9.74 9.52 9.61
    Resistance 2 (R2) 9.52 9.34 9.51 9.57
    Resistance 1 (R1) 9.27 9.23 9.16 9.26 9.53
    Pivot Point 9.05 9.05 9.00 9.05 9.05
    Support 1 (S1) 8.81 8.87 8.70 8.80 8.53
    Support 2 (S2) 8.59 8.76 8.58 8.49
    Support 3 (S3) 8.34 8.59 8.45
    Support 4 (S4) 8.33